Metsera (MTSR) is up 23.5%, or $12.26 to $64.47.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MTSR:
- Midday Fly By: Big Tech reports, Novo tops Pfizer bid for Metsera
- M&A War: Pfizer Blasts Rival Novo Nordisk for “Reckless” $8.5B Hijack of Metsera Obesity Deal
- Metsera Considers Novo Nordisk’s Superior Proposal
- Metsera receives unsolicted proposal from Novo Nordisk
- Novo Nordisk offers to buy Metsera for up to $77.75 per share, or $9B